A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction

AIMS: The PARADIGM-HF and PARAGON-HF trials tested sacubitril/valsartan against active controls given renin–angiotensin system inhibitors (RASi) are ethically mandated in heart failure (HF) with reduced ejection fraction and are used in the vast majority of patients with HF with preserved ejection f...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Heart J
Main Authors: Vaduganathan, Muthiah, Jhund, Pardeep S, Claggett, Brian L, Packer, Milton, Widimský, Jiri, Seferovic, Petar, Rizkala, Adel, Lefkowitz, Martin, Shi, Victor, McMurray, John J V, Solomon, Scott D
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Fast Track Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7327532/
https://ncbi.nlm.nih.gov/pubmed/32221596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehaa184
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados